Evidence map›Paper›PMID 35222671›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Boldine, an Alkaloid from

Priscila de Souza, Rita de Cássia Vilhena da Silva, Luisa Mota da Silva, Viviane Miranda Bispo Steimbach, Karyne Garcia Tafarelo Moreno, Arquimedes Gasparotto Junior

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Targeting L-arginine/NO/cGMP/KFrontiers in pharmacology · 2025
    Review
  3. Efficacy and Safety of Boldine Combined withMedicina (Kaunas, Lithuania) · 2024
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Priscila de SouzaGraduate Program in Pharmaceutical Sciences, Nucleus of Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale do Itajaí, Itajaí, SC, Brazil.ORCID https://orcid.org/0000-0002-5251-5642
Rita de Cássia Vilhena da SilvaGraduate Program in Pharmaceutical Sciences, Nucleus of Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale do Itajaí, Itajaí, SC, Brazil.
Luisa Mota da SilvaGraduate Program in Pharmaceutical Sciences, Nucleus of Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale do Itajaí, Itajaí, SC, Brazil.
Viviane Miranda Bispo SteimbachGraduate Program in Pharmaceutical Sciences, Nucleus of Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale do Itajaí, Itajaí, SC, Brazil.
Karyne Garcia Tafarelo MorenoLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Universidade Federal da Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Arquimedes Gasparotto JuniorLaboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Universidade Federal da Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.ORCID https://orcid.org/0000-0003-3433-5098
Universidade do Vale do Itajaí · BRUniversidade Federal da Grande Dourados · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Boldine, 2,9-dihydroxy-1,10-dimethoxyaporphine, is the main alkaloid found in the leaves and bark of

Identifiers

PMID35222671
PMCPMC8865971
OpenAlexW4212926851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.